Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 323

1.

Loss of resistin ameliorates hyperlipidemia and hepatic steatosis in leptin-deficient mice.

Singhal NS, Patel RT, Qi Y, Lee YS, Ahima RS.

Am J Physiol Endocrinol Metab. 2008 Aug;295(2):E331-8. doi: 10.1152/ajpendo.00577.2007. Epub 2008 May 27.

2.

Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice.

Begriche K, Lettéron P, Abbey-Toby A, Vadrot N, Robin MA, Bado A, Pessayre D, Fromenty B.

Am J Physiol Endocrinol Metab. 2008 May;294(5):E939-51. doi: 10.1152/ajpendo.00379.2007. Epub 2008 Mar 18.

3.

Loss of resistin improves glucose homeostasis in leptin deficiency.

Qi Y, Nie Z, Lee YS, Singhal NS, Scherer PE, Lazar MA, Ahima RS.

Diabetes. 2006 Nov;55(11):3083-90.

4.

Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.

Malloy VL, Perrone CE, Mattocks DA, Ables GP, Caliendo NS, Orentreich DS, Orentreich N.

Metabolism. 2013 Nov;62(11):1651-61. doi: 10.1016/j.metabol.2013.06.012. Epub 2013 Aug 5.

PMID:
23928105
5.

Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.

Dentin R, Benhamed F, Hainault I, Fauveau V, Foufelle F, Dyck JR, Girard J, Postic C.

Diabetes. 2006 Aug;55(8):2159-70.

6.

Beta-aminoisobutyric acid prevents diet-induced obesity in mice with partial leptin deficiency.

Begriche K, Massart J, Abbey-Toby A, Igoudjil A, Lettéron P, Fromenty B.

Obesity (Silver Spring). 2008 Sep;16(9):2053-67. doi: 10.1038/oby.2008.337.

7.

Adiponectin is stimulated by adrenalectomy in ob/ob mice and is highly correlated with resistin mRNA.

Makimura H, Mizuno TM, Bergen H, Mobbs CV.

Am J Physiol Endocrinol Metab. 2002 Dec;283(6):E1266-71. Epub 2002 Aug 13.

8.

Diet-genotype interactions in the early development of obesity and insulin resistance in mice with a genetic deficiency in tumor necrosis factor-alpha.

Bouter B, Geary N, Langhans W, Asarian L.

Metabolism. 2010 Jul;59(7):1065-73. doi: 10.1016/j.metabol.2009.11.003. Epub 2009 Dec 31.

PMID:
20045154
9.

Conjugated linoleic acid fails to worsen insulin resistance but induces hepatic steatosis in the presence of leptin in ob/ob mice.

Wendel AA, Purushotham A, Liu LF, Belury MA.

J Lipid Res. 2008 Jan;49(1):98-106. Epub 2007 Sep 28.

10.

Pollock oil supplementation modulates hyperlipidemia and ameliorates hepatic steatosis in mice fed a high-fat diet.

Yang ZH, Miyahara H, Takeo J, Hatanaka A, Katayama M.

Lipids Health Dis. 2011 Oct 25;10:189. doi: 10.1186/1476-511X-10-189.

11.

Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting.

Rajala MW, Qi Y, Patel HR, Takahashi N, Banerjee R, Pajvani UB, Sinha MK, Gingerich RL, Scherer PE, Ahima RS.

Diabetes. 2004 Jul;53(7):1671-9.

12.

Circulating resistin in lean, obese, and insulin-resistant mouse models: lack of association with insulinemia and glycemia.

Lee JH, Bullen JW Jr, Stoyneva VL, Mantzoros CS.

Am J Physiol Endocrinol Metab. 2005 Mar;288(3):E625-32. Epub 2004 Nov 2.

13.

A novel aminosterol reverses diabetes and fatty liver disease in obese mice.

Takahashi N, Qi Y, Patel HR, Ahima RS.

J Hepatol. 2004 Sep;41(3):391-8.

PMID:
15336441
14.

Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice.

Yu XX, Murray SF, Pandey SK, Booten SL, Bao D, Song XZ, Kelly S, Chen S, McKay R, Monia BP, Bhanot S.

Hepatology. 2005 Aug;42(2):362-71.

PMID:
16001399
15.

Leptin treatment markedly increased plasma adiponectin but barely decreased plasma resistin of ob/ob mice.

Delporte ML, El Mkadem SA, Quisquater M, Brichard SM.

Am J Physiol Endocrinol Metab. 2004 Sep;287(3):E446-53. Epub 2004 May 4.

16.

Nonalcoholic Fatty gallbladder disease: the influence of diet in lean and obese mice.

Goldblatt MI, Swartz-Basile DA, Al-Azzawi HH, Tran KQ, Nakeeb A, Pitt HA.

J Gastrointest Surg. 2006 Feb;10(2):193-201.

PMID:
16455450
17.
18.
19.

Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice.

Nuotio-Antar AM, Hachey DL, Hasty AH.

Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1517-28. Epub 2007 Sep 18. Erratum in: Am J Physiol Endocrinol Metab. 2008 May;294(5):E993.

20.

Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.

Matsusue K, Haluzik M, Lambert G, Yim SH, Gavrilova O, Ward JM, Brewer B Jr, Reitman ML, Gonzalez FJ.

J Clin Invest. 2003 Mar;111(5):737-47.

Items per page

Supplemental Content

Write to the Help Desk